The Norwegian hydrogen specialist has entered a holding pattern that feels increasingly uncomfortable. With no fresh corporate announcements, contract wins, or regulatory decisions to latch onto, Nel ASA’s share price is drifting lower on inertia alone — a slow bleed that tells the story of a company caught between a demanding capital programme and an operating model that is yet to prove itself.
At the latest check, the stock was changing hands at €0.1924, having shed 7.0 percent over the past seven sessions. The slide has unfolded without any identifiable company-specific trigger; rather, it reflects a market that has run out of reasons to buy and is slowly repricing the known negatives.
The Summer Numbers Still Cast a Long Shadow
The root of the current malaise can be traced back to mid-July. When Nel published its second-quarter results on the 15th, the figures made for sobering reading: order intake of NOK 230 million, customer contract revenues of NOK 153 million, and an EBITDA loss of NOK 155 million. Analysts and commentators alike have since tied the equity’s weak trajectory directly to these metrics — a loss-making operation that has weighed on sentiment for weeks.
Compounding the operational strain is a leadership transition that was announced but not yet executed. CEO Håkon Volldal remains in post until the end of the year, yet his impending departure has injected a layer of strategic uncertainty into a period when the company is committing significant capital to expanding production capacity at Herøya to 500 megawatts by the end of 2026. That expansion demands resources at precisely the moment the core business is bleeding red ink.
Should investors sell immediately? Or is it worth buying Nel ASA?
Analyst Caution Reinforces the Gloomy Picture
The most recent — and only clearly dated — analyst action came on 5 August, when J.P. Morgan trimmed its price target for Nel from NOK 2.90 to NOK 1.80, cutting nearly a third of the previous target while maintaining a Neutral rating. The adjustment arrived as the market was still digesting the weak quarterly numbers, making it feel more like an acknowledgment of reality than a fresh assessment of the company’s longer-term prospects. No other major house has weighed in since, leaving J.P. Morgan’s cautious stance as the prevailing voice in the conversation.
That analyst scepticism is mirrored in the chart. The share now sits 47 percent below its 52-week high of €0.3655, reached back in May — a stark illustration of how far investor confidence has fallen over the course of the year. Yet the picture is not uniformly bleak: the stock remains up 1.9 percent since the start of January, and the current level still holds above the yearly low.
A Waiting Game With Few Levers to Pull
The backdrop is further complicated by a series of unresolved themes that continue to linger in the background without providing any fresh impetus. EU funding decisions, the leadership change flagged alongside the quarterly results, and delayed hydrogen projects at major energy companies all remain part of the narrative — but none has offered a reason for the market to reassess the stock.
For now, Nel finds itself in a phase of observation. The combination of a weak earnings profile, an imminent change at the top, and a capital-intensive expansion programme leaves little room for near-term share price catalysts. The critical question is whether the planned capacity build-out, due to conclude by the end of 2026, will eventually translate into a stronger order pipeline. Until that connection is demonstrated, investors are likely to remain on the sidelines, watching for the next corporate update that might finally break the stalemate.
Ad
Nel ASA Stock: Buy or Sell?! New Nel ASA Analysis from August 19 delivers the answer:
The latest Nel ASA figures speak for themselves: Urgent action needed for Nel ASA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 19.
Nel ASA: Buy or sell? Read more here...
